Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perspective
  • Published:

Genomic resources for the study of neuropsychiatric disorders

Abstract

The National Institute of Mental Health (NIMH) has made sustained investments in the development of genomic resources over the last two decades. These investments have led to the development of the largest biorepository for psychiatric genetics as a centralized national resource. In the realm of genomic resources, NIMH has been supporting large team science (TS) consortia focused on gene discovery, fine mapping of loci, and functional genomics using state-of-the-art technologies. The scientific output from these efforts has not only begun to transform our understanding of the genetic architecture of neuropsychiatric disorders, but it has also led to a broader cultural change among the investigator community towards deeper collaborations and broad pre-publication sharing of data and resources. The NIMH supported efforts have led to a vast increase in the amount of genetic and genomic resources available to the mental health research community. Here we provide an account of the existing resources and estimates of the scale and scope of what will be available in the near future. All biosamples and data described are intended for broad sharing with researchers worldwide, as allowed by the subject consent and applicable laws.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Bloom DE, Cafiero E, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S et al The Global Economic Burden of Noncommunicable Diseases. World Economic Forum and the Harvard School of Public Health, 2011 [online], Available at: http://www3.weforum.org/docs/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf.

  2. Eaton WW, Martins SS, Nestadt G, Bienvenu OJ, Clarke D, Alexandre P . The burden of mental disorders. Epidemiol Rev 2008; 30: 1–14.

    Article  Google Scholar 

  3. Lehner T, Senthil G, Addington AM . Convergence of advances in genomics, team science, and repositories as drivers of progress in psychiatric genomics. Biol Psychiatry 2015; 77: 6–14.

    Article  Google Scholar 

  4. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421–427.

    Article  Google Scholar 

  5. Moldin SO . NIMH Human Genetics Initiative: 2003 update. Am J Psychiatry 2003; 160: 621–622.

    Article  Google Scholar 

  6. Parikshak NN, Luo R, Zhang A, Won H, Lowe JK, Chandran V et al. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 2013; 155: 1008–1021.

    Article  CAS  Google Scholar 

  7. Shcheglovitov A, Shcheglovitova O, Yazawa M, Portmann T, Shu R, Sebastiano V et al. SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature 2013; 503: 267–271.

    Article  CAS  Google Scholar 

  8. Wang Y, Dolmetsch R . In vitro human corticogenesis. Neuron 2013; 77: 379–381.

    Article  CAS  Google Scholar 

  9. He X, Sanders SJ, Liu L, De Rubeis S, Lim ET, Sutcliffe JS et al. Integrated model of de novo and inherited genetic variants yields greater power to identify risk genes. PLoS Genet 2013; 9: e1003671.

    Article  CAS  Google Scholar 

  10. Ionita-Laza I, Lee S, Makarov V, Buxbaum JD, Lin X . Sequence kernel association tests for the combined effect of rare and common variants. Am J Hum Genet 2013; 92: 841–853.

    Article  CAS  Google Scholar 

  11. Psychiatric GWAS Consortium Steering Committee. A framework for interpreting genome-wide association studies of psychiatric disorders. Mol Psychiatry 2009; 14: 10–17.

    Article  Google Scholar 

  12. Buxbaum JD, Daly MJ, Devlin B, Lehner T, Roeder K, State MW et al. The autism sequencing consortium: large-scale, high-throughput sequencing in autism spectrum disorders. Neuron 2012; 76: 1052–1056.

    Article  CAS  Google Scholar 

  13. De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 2014; 515: 209–215.

    Article  CAS  Google Scholar 

  14. Parikshak NN, Gandal MJ, Geschwind DH . Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders. Nat Rev Genet 2015; 16: 441–458.

    Article  CAS  Google Scholar 

  15. Willsey AJ, Sanders SJ, Li M, Dong S, Tebbenkamp AT, Muhle RA et al. Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell 2013; 155: 997–1007.

    Article  CAS  Google Scholar 

  16. Nichols L, Freund M, Ng C, Kau A, Parisi M, Taylor A et al. The National Institutes of Health Neurobiobank: a federated national network of human brain and tissue repositories. Biol Psychiatry 2014; 75: e21–e22.

    Article  Google Scholar 

  17. PsychENCODE Consortium PsychENCODE Consortium Akbarian S, Liu C, Knowles JA, Vaccarino FM, Farnham PJ et al. The PsychENCODE project. Nat Neurosci 2015; 18: 1707–1712.

    Article  Google Scholar 

  18. Shabani M, Knoppers BM, Borry P . From the principles of genomic data sharing to the practices of data access committees. EMBO Mol Med 2015; 7: 507–509.

    Article  CAS  Google Scholar 

  19. Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 2016; 536: 285–291.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr John Rice and his group at Washington University in St Louis; Drs Jay Tischfield and Linda Brzustowicz, and their group at Rutgers University; Dr Yigal Arens and his group at the Information Sciences Institute at University of Southern California, and the dbGaP and NDA staff for their help with data and sample accounting. We also acknowledge the efforts of several members of our TS and functional genomics consortia in providing up to date details on their data generation efforts, including Drs Pamela Sklar and Nenad Sestan.

Disclaimer

The views and opinions expressed in this article are those of the authors and should not be construed to represent the views of any of the sponsoring organization, agencies or the United States government.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T Lehner.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Molecular Psychiatry website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Senthil, G., Dutka, T., Bingaman, L. et al. Genomic resources for the study of neuropsychiatric disorders. Mol Psychiatry 22, 1659–1663 (2017). https://doi.org/10.1038/mp.2017.29

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/mp.2017.29

This article is cited by

Search

Quick links